Beijing Beilu Pharmaceutical Co (SZSE:300016) Total Equity : ¥1,844 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Total Equity?

Beijing Beilu Pharmaceutical Co's total equity for the quarter that ended in Mar. 2025 was ¥1,844 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Beijing Beilu Pharmaceutical Co Total Equity Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Total Equity Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

1,892.07

2,086.04

1,923.29

1,786.31

1,829.49

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Equity	Get a 7-Day Free Trial															1,799.30	1,842.79	1,848.01	1,829.49	1,844.30

Beijing Beilu Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Beijing Beilu Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	2977.531	-	1148.043
	=	1,829

Beijing Beilu Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2025 )	-	Total Liabilities(Q: Mar. 2025 )
	=	3206.879	-	1362.576
	=	1,844

Beijing Beilu Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Total Equity

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines